We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+32.82%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.14B
AUM Growth
+$551M
Cap. Flow
+$421M
Cap. Flow %
37.05%
Top 10 Hldgs %
39.86%
Holding
141
New
51
Increased
36
Reduced
11
Closed
41

Top Buys

Rank Stock Value
1
VRAY
ViewRay, Inc.
VRAY
+$18.2M
2
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$10.6M
3
IMDX
Insight Molecular Diagnostics
IMDX
+$10.3M
4
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$5.48M
5
SRACU
Stable Road Acquisition Corp. Unit
SRACU
+$4.41M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$11.1M
2
GILD icon
Gilead Sciences
GILD
+$9.51M
3
SNN icon
Smith & Nephew
SNN
+$8.66M
4
BAX icon
Baxter International
BAX
+$4.96M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.45M

Sector Composition

Rank Sector Weight
1 Healthcare 26.48%
2 Industrials 0.92%
3 Consumer Staples 0.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$156M 13.77%
+486,200
New +$150M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$42.7M 3.76%
258,000
+133,000
+106% +$21M
XLV icon
3
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.8B
$41M 3.61%
403,000
+153,000
+61% +$14.7M
XBI icon
4
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$40.7M 3.58%
428,000
+278,000
+185% +$24M
ABMD
5
PUT
DELISTED
Abiomed Inc
ABMD
$30.2M 2.66%
+177,000
New +$32.8M
MDT icon
6
CALL
Medtronic
MDT
$111B
$30.2M 2.65%
+266,000
New +$29.2M
IHI icon
7
PUT
iShares US Medical Devices ETF
IHI
$3.37B
$28.8M 2.53%
+654,000
New +$27.5M
INSP icon
8
Inspire Medical Systems
INSP
$1.5B
$28.5M 2.5%
383,640
+25,940
+7% +$1.67M
UNH icon
9
PUT
UnitedHealth
UNH
$377B
$27.6M 2.43%
94,000
+64,000
+213% +$16.7M
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
$26.8M 2.36%
964,570
+90,770
+10% +$2.2M
VRAY
11
DELISTED
ViewRay, Inc.
VRAY
$26.8M 2.36%
6,352,939
+5,617,945
+764% +$18.2M
FXH icon
12
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.06B
$22.6M 1.99%
269,000
+19,000
+8% +$1.5M
QGEN icon
13
CALL
Qiagen
QGEN
$8.73B
$20M 1.76%
+559,232
New +$20.8M
ZBH icon
14
Zimmer Biomet
ZBH
$18.8B
$19.6M 1.72%
134,714
+13,749
+11% +$1.9M
ICUI icon
15
ICU Medical
ICUI
$4.32B
$19.3M 1.7%
103,320
+10,820
+12% +$1.86M
STAA icon
16
STAAR Surgical
STAA
$1.21B
$19M 1.67%
540,110
+36,098
+7% +$1.19M
ESTA icon
17
Establishment Labs
ESTA
$2.73B
$18.9M 1.66%
682,600
-62,563
-8% -$1.39M
NSTG
18
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
$18.2M 1.6%
654,000
-56,000
-8% -$1.36M
XENT
19
DELISTED
Intersect ENT, Inc
XENT
$18.2M 1.6%
730,360
+60,360
+9% +$1.22M
BHVN
20
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$17.8M 1.57%
327,000
+27,000
+9% +$1.34M
ILMN icon
21
CALL
Illumina
ILMN
$30B
$17.3M 1.52%
53,456
+22,616
+73% +$6.85M
BAX icon
22
CALL
Baxter International
BAX
$14.5B
$17.2M 1.51%
+205,500
New +$17M
XENT
23
CALL
DELISTED
Intersect ENT, Inc
XENT
$16.3M 1.43%
654,000
-121,000
-16% -$2.45M
SRPT icon
24
PUT
Sarepta Therapeutics
SRPT
$1.68B
$14.1M 1.24%
109,000
+9,000
+9% +$908K
AMRN
25
PUT
Amarin Corp
AMRN
$297M
$14M 1.23%
+32,700
New +$12.4M
1
2 3 4 5

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
SR
Swiss Re Zurich, Switzerland $16.4M AUM
TC
TradeLink Capital Chicago, Illinois $13.2M AUM 33.27% 1-Year Est. Return

Pura Vida Investments's Q4 2019 Portfolio in Review

As of Q4 2019, Pura Vida Investments held 141 positions worth $1.14B, up 94% from $585M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Pura Vida Investments deployed $421M of net new capital in Q4 2019, opening 51 new positions and adding to 36 existing holdings. Its largest new stake was Insight Molecular Diagnostics: 284,829 shares worth $12.8M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 40% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was Establishment Labs, an estimated $1.39M trimmed.

  • Pura Vida Investments's largest Q4 2019 buy was Insight Molecular Diagnostics: 284,829 shares worth $12.8M.
  • Pura Vida Investments added most to ViewRay, Inc. in Q4 2019, an estimated $18.2M increase.
  • Pura Vida Investments's biggest Q4 2019 reduction was Establishment Labs, cutting an estimated $1.39M.
  • Pura Vida Investments fully exited Regeneron Pharmaceuticals in Q4 2019, selling an estimated $11.1M.
  • Pura Vida Investments's ten largest holdings make up 40% of its $1.14B portfolio in Q4 2019.
  • Pura Vida Investments opened 51 new positions and closed 41 in Q4 2019.
  • Pura Vida Investments's portfolio value rose 94% quarter-over-quarter to $1.14B.

Based on Pura Vida Investments's 13F filing for Q4 2019, filed 14 Feb 2020.